398 related articles for article (PubMed ID: 24775711)
1. Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease.
Sikorska M; Lanthier P; Miller H; Beyers M; Sodja C; Zurakowski B; Gangaraju S; Pandey S; Sandhu JK
Neurobiol Aging; 2014 Oct; 35(10):2329-46. PubMed ID: 24775711
[TBL] [Abstract][Full Text] [Related]
2. Orally delivered water soluble Coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson's disease.
Muthukumaran K; Leahy S; Harrison K; Sikorska M; Sandhu JK; Cohen J; Keshan C; Lopatin D; Miller H; Borowy-Borowski H; Lanthier P; Weinstock S; Pandey S
BMC Neurosci; 2014 Jan; 15():21. PubMed ID: 24483602
[TBL] [Abstract][Full Text] [Related]
3. Genetic susceptibility model of Parkinson's disease resulting from exposure of DJ-1 deficient mice to MPTP: evaluation of neuroprotection by Ubisol-Q10.
Muthukumaran K; Smith J; Jasra H; Sikorska M; Sandhu JK; Cohen J; Lopatin D; Pandey S
J Parkinsons Dis; 2014; 4(3):523-530. PubMed ID: 25061060
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.
Yang L; Calingasan NY; Wille EJ; Cormier K; Smith K; Ferrante RJ; Beal MF
J Neurochem; 2009 Jun; 109(5):1427-39. PubMed ID: 19476553
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress.
Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ
Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective Effects of Antidepressants via Upregulation of Neurotrophic Factors in the MPTP Model of Parkinson's Disease.
Shadfar S; Kim YG; Katila N; Neupane S; Ojha U; Bhurtel S; Srivastav S; Jeong GS; Park PH; Hong JT; Choi DY
Mol Neurobiol; 2018 Jan; 55(1):554-566. PubMed ID: 27975170
[TBL] [Abstract][Full Text] [Related]
8. Coenzyme Q(10) provides neuroprotection in iron-induced apoptosis in dopaminergic neurons.
Kooncumchoo P; Sharma S; Porter J; Govitrapong P; Ebadi M
J Mol Neurosci; 2006; 28(2):125-41. PubMed ID: 16679553
[TBL] [Abstract][Full Text] [Related]
9. Ubisol-Q
Wear D; Vegh C; Sandhu JK; Sikorska M; Cohen J; Pandey S
Antioxidants (Basel); 2021 May; 10(5):. PubMed ID: 34064983
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of coenzyme Q₁₀ reduces MPTP-induced loss of dopaminergic nerve terminals in the striatum in mice.
Kobayashi S; Muroyama A; Matsushima H; Yoshimura I; Mitsumoto Y
Neurol Sci; 2012 Feb; 33(1):195-9. PubMed ID: 21598008
[TBL] [Abstract][Full Text] [Related]
11. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease.
Pupyshev AB; Tikhonova MA; Akopyan AA; Tenditnik MV; Dubrovina NI; Korolenko TA
Pharmacol Biochem Behav; 2019 Feb; 177():1-11. PubMed ID: 30582934
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson's disease.
Bahdoudi S; Ghouili I; Hmiden M; do Rego JL; Lefranc B; Leprince J; Chuquet J; do Rego JC; Marcher AB; Mandrup S; Vaudry H; Tonon MC; Amri M; Masmoudi-Kouki O; Vaudry D
Cell Mol Life Sci; 2018 Jun; 75(11):2075-2091. PubMed ID: 29264673
[TBL] [Abstract][Full Text] [Related]
14. Dangguijakyak-san protects dopamine neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity under postmenopausal conditions.
Lee JM; Hwang DS; Kim HG; Lee CH; Oh MS
J Ethnopharmacol; 2012 Feb; 139(3):883-8. PubMed ID: 22178176
[TBL] [Abstract][Full Text] [Related]
15. The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease.
Prediger RD; Aguiar AS; Moreira EL; Matheus FC; Castro AA; Walz R; De Bem AF; Latini A; Tasca CI; Farina M; Raisman-Vozari R
Curr Pharm Des; 2011; 17(5):489-507. PubMed ID: 21375482
[TBL] [Abstract][Full Text] [Related]
16. Improved neuroprotective effects of resveratrol-loaded polysorbate 80-coated poly(lactide) nanoparticles in MPTP-induced Parkinsonism.
da Rocha Lindner G; Bonfanti Santos D; Colle D; Gasnhar Moreira EL; Daniel Prediger R; Farina M; Khalil NM; Mara Mainardes R
Nanomedicine (Lond); 2015; 10(7):1127-38. PubMed ID: 25929569
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease model.
Ghosh A; Chandran K; Kalivendi SV; Joseph J; Antholine WE; Hillard CJ; Kanthasamy A; Kanthasamy A; Kalyanaraman B
Free Radic Biol Med; 2010 Dec; 49(11):1674-84. PubMed ID: 20828611
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo.
Guo B; Xu D; Duan H; Du J; Zhang Z; Lee SM; Wang Y
Biol Pharm Bull; 2014; 37(2):274-85. PubMed ID: 24305623
[TBL] [Abstract][Full Text] [Related]
19. Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model.
Li H; Park G; Bae N; Kim J; Oh MS; Yang HO
J Ethnopharmacol; 2015 Dec; 176():336-44. PubMed ID: 26593210
[TBL] [Abstract][Full Text] [Related]
20. Mulberry fruit ameliorates Parkinson's-disease-related pathology by reducing α-synuclein and ubiquitin levels in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model.
Gu PS; Moon M; Choi JG; Oh MS
J Nutr Biochem; 2017 Jan; 39():15-21. PubMed ID: 27741433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
